International Medical Case Reports Journal (Nov 2022)
Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis
Abstract
Adrian T Babel,1,2 Eric K Chin,3,4 David RP Almeida2 1Boonshoft School of Medicine, Dayton, OH, USA; 2Erie Retinal Surgery, Erie, PA, USA; 3Retina Consultants of Southern California, Redlands, CA, USA; 4Loma Linda Eye Institute, Veterans Affair Hospital, Loma Linda, CA, USACorrespondence: David RP Almeida, Erie Retinal Surgery, Erie Retina Research, 300 State Street, Suite 201, Erie, PA, 16507, USA, Tel +1 814 456-4241, Fax +1 814 453 3354, Email [email protected]: Our case emphasizes the utility of long-acting intravitreal fluocinolone implants (YUTIQ) for managing recalcitrant forms of non-infectious posterior uveitis, NIPU.Patient: We present a case of bilateral NIPU refractory to topical corticosteroids and intravitreal triamcinolone and dexamethasone.Results: Management with bilateral YUTIQ improved local ocular inflammatory control with improved vision and anatomical outcomes.Conclusion: NIPU can develop into recurrent forms resistant to short-acting therapeutics. Long-acting efficacy with YUTIQ emphasizes the need to recognize such refractory NIPU cases.Keywords: non-infectious uveitis, NIU, fluocinolone acetonide implant
